Cross sectional study of 301 adult patients with Covid-19 Pneumonia treated with corticosteroid and/or colchicine
A cross sectional study of 301 adult patients with Covid-19 Pneumonia confirmed by Real-Time Polymerase Chain Reaction for SARS-CoV2 (RT-PCR SARS-CoV2), Berlin protocol, who required hospitalization in three hospitals in Antioquia, Colombia. Patients were treated according to the institutional protocol (from March 20, 2020 to June 30, 2020) with corticosteroid if the patient required supplemental oxygen. From July 1, 2020, the management protocol changed with the addition of colchicine to all patients admitted to the institutions. The treatment was supervised and monitored by the same specialist in infectology of the institutions. We describe the clinical manifestations and outcomes of the patients who received these treatments. The patient's information was analyzed according to the outcome of interest (alive/dead) with univariate, bivariate, and multivariate measures to adjust the variables that presented statistical association.
Study Type
OBSERVATIONAL
Enrollment
301
We describe the clinical outcome of patients treated with corticosteroid and colchicine
Clínica Medellín - Grupo Quirónsalud
Medellín, Antioquia, Colombia
Outcome
Dead or alive
Time frame: March 20 to August 07, 2020
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.